CD40LG and myocardial infarction: C7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) and oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI16) studies showed that increased sCD40L levels were associated with a higher risk for death and non-fatal myocardial infarction [23,24].